Calpain cleavage regulates the protein stability of p73

Biochemical and Biophysical Research Communications

Volumn 333, Issue 3, 2005, Pages 954-960

  Munarriz, Eliana ^a   Bano, Daniele ^a   Sayan, A Emre ^a   Rossi, Mario ^a   Melino, Gerry ^a,b   Nicotera, Pierluigi ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Apoptosis; Calcium; Calpains; Calpastatin; Cell death; Neural development; p53; p73; Protein degradation; Protein stability; TCR apoptosis

Indexed keywords

CALPAIN; CALPASTATIN; ISOPROTEIN; PROLINE; PROTEIN P73;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN STABILITY;

BASE SEQUENCE; CALPAIN; CELL DEATH; CELL LINE, TUMOR; DNA PRIMERS; DNA-BINDING PROTEINS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENES, TUMOR SUPPRESSOR; HUMANS; HYDROLYSIS; NUCLEAR PROTEINS; PLASMIDS; PROTEIN ISOFORMS; TUMOR SUPPRESSOR PROTEINS;

EID: 20744458282     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.05.188     Document Type: Article

References (34)

1. M. Kaghad, H. Bonnet, A. Yang, L. Creancier, J.C. Biscan, A. Valent, A. Minty, P. Chalon, J.M. Lelias, X. Dumont, P. Ferrara, F. McKeon, and D. Caput Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers Cell 90 1997 809 819
2. A. Yang, and F. McKeon P63 and P73: P53 mimics, menaces and more Nat. Rev. Mol. Cell. Biol. 1 2000 199 207
3. A. Yang, M. Kaghad, D. Caput, and F. McKeon On the shoulders of giants: p63, p73 and the rise of p53 Trends Genet. 18 2002 90 95
4. G. Melino, V. De Laurenzi, and K.H. Vousden p73: friend or foe in tumorigenesis Nat. Rev. Cancer 2 2002 605 615
5. G. Melino, X. Lu, M. Gasco, T. Crook, and R.A. Knight Functional regulation of p73 and p63: development and cancer Trends Biochem. Sci. 28 2003 663 670
6. A.E. Sayan, M. Rossi, G. Melino, and R.A. Knight p73: in silico evidence for a putative third promoter region Biochem. Biophys. Res. Commun. 313 2004 765 770
7. V. De Laurenzi, A. Costanzo, D. Barcaroli, A. Terrinoni, M. Falco, M. Annicchiarico-Petruzzelli, M. Levrero, and G. Melino Two new p73 splice variants, gamma and delta, with different transcriptional activity J. Exp. Med. 188 1998 1763 1768
8. Y. Ueda, M. Hijikata, S. Takagi, T. Chiba, and K. Shimotohno New p73 variants with altered C-terminal structures have varied transcriptional activities Oncogene 18 1999 4993 4998
9. Y. Ueda, M. Hijikata, S. Takagi, R. Takada, S. Takada, T. Chiba, and K. Shimotohno p73beta, a variant of p73, enhances Wnt/beta-catenin signaling in Saos-2 cells Biochem. Biophys. Res. Commun. 283 2001 327 333
10. T.J. Grob, U. Novak, C. Maisse, D. Barcaroli, A.U. Luthi, F. Pirnia, B. Hugli, H.U. Graber, V. De Laurenzi, M.F. Fey, G. Melino, and A. Tobler Human delta Np73 regulates a dominant negative feedback loop for TAp73 and p53 Cell Death Differ. 8 2001 1213 1223
11. O. Ishimoto, C. Kawahara, K. Enjo, M. Obinata, T. Nukiwa, and S. Ikawa Possible oncogenic potential of DeltaNp73: a newly identified isoform of human p73 Cancer Res. 62 2002 636 641
12. I. Fillippovich, N. Sorokina, M. Gatei, Y. Haupt, K. Hobson, E. Moallem, K. Spring, M. Mould, M.A. McGuckin, M.F. Lavin, and K.K. Khanna Transactivation-deficient p73alpha (p73Deltaexon2) inhibits apoptosis and competes with p53 Oncogene 20 2001 514 522
13. T. Stiewe, and B.M. Putzer Role of p73 in malignancy: tumor suppressor or oncogene? Cell Death Differ. 9 2002 237 245
14. H. Gonen, D. Shkedy, S. Barnoy, N.S. Kosower, and A. Ciechanover On the involvement of calpains in the degradation of the tumor suppressor protein p53 FEBS Lett. 406 1997 17 22
15. M.H. Kubbutat, and K.H. Vousden Proteolytic cleavage of human p53 by calpain: a potential regulator of protein stability Mol. Cell. Biol. 17 1997 460 468
16. 2+/calmodulin-dependent protein kinase type IV in cultured neurons J. Biol. Chem. 280 2005 2165 2175
17. P. Tompa, P. Buzder-Lantos, A. Tantos, A. Farkas, A. Szilagyi, Z. Banoczi, F. Hudecz, and P. Friedrich On the sequential determinants of calpain cleavage J. Biol. Chem. 279 2004 20775 20785
18. F. Bernassola, P. Salomoni, A. Oberst, C.J. Di Como, M. Pagano, G. Melino, and P.P. Pandolfi Ubiquitin-dependent degradation of p73 is inhibited by PML J. Exp. Med. 199 2004 1545 1557
19. E. Balint, S. Bates, and K.H. Vousden Mdm2 binds p73 alpha without targeting degradation Oncogene 18 1999 3923 3929
20. M. Rossi, V. De Laurenzi, E. Munarriz, D.R. Green, Y.C. Liu, K.H. Vousden, G. Cesareni, and G. Melino The ubiquitin-protein ligase Itch regulates p73 stability Embo J. 24 2005 836 848
21. C. Maisse, E. Munarriz, D. Barcaroli, G. Melino, and V. De Laurenzi DNA damage induces the rapid and selective degradation of the DeltaNp73 isoform, allowing apoptosis to occur Cell Death Differ. 11 2004 685 687
22. R. Agami, G. Blandino, M. Oren, and Y. Shaul Interaction of c-Abl and p73alpha and their collaboration to induce apoptosis Nature 399 1999 809 813
23. Z.M. Yuan, H. Shioya, T. Ishiko, X. Sun, J. Gu, Y.Y. Huang, H. Lu, S. Kharbanda, R. Weichselbaum, and D. Kufe p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage Nature 399 1999 814 817
24. J.G. Gong, A. Costanzo, H.Q. Yang, G. Melino, W.G. Kaelin Jr., M. Levrero, and J.Y. Wang The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage Nature 399 1999 806 809
25. G. Asher, P. Tsvetkov, C. Kahana, and Y. Shaul A mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73 Genes Dev. 19 2005 316 321
26. W. Zhang, Q. Lu, Z.J. Xie, and R.L. Mellgren Inhibition of the growth of WI-38 fibroblasts by benzyloxycarbonyl-Leu-Leu-Tyr diazomethyl ketone: evidence that cleavage of p53 by a calpain-like protease is necessary for G1 to S-phase transition Oncogene 14 1997 255 263
27. M. Pariat, S. Carillo, M. Molinari, C. Salvat, L. Debussche, L. Bracco, J. Milner, and M. Piechaczyk Proteolysis by calpains: a possible contribution to degradation of p53 Mol. Cell. Biol. 17 1997 2806 2815
28. I.A. Atencio, M. Ramachandra, P. Shabram, and G.W. Demers Calpain inhibitor 1 activates p53-dependent apoptosis in tumor cell lines Cell Growth Differ. 11 2000 247 253
29. M. Sedarous, E. Keramaris, M. O'Hare, E. Melloni, R.S. Slack, J.S. Elce, P.A. Greer, and D.S. Park Calpains mediate p53 activation and neuronal death evoked by DNA damage J. Biol. Chem. 278 2003 26031 26038
30. E. Munarriz, D. Barcaroli, A. Stephanou, P.A. Townsend, C. Maisse, A. Terrinoni, M.H. Neale, S.J. Martin, D.S. Latchman, R.A. Knight, G. Melino, and V. De Laurenzi PIAS-1 is a checkpoint regulator which affects exit from G1 and G2 by sumoylation of p73 Mol. Cell. Biol. 24 2004 10593 10610
31. 2+ exchanger in excitotoxicity Cell 120 2005 275 285
32. V. Gottifredi, G. Pelicci, E. Munarriz, R. Maione, P.G. Pelicci, and P. Amati Polyomavirus large T antigen induces alterations in cytoplasmic signalling pathways involving Shc activation J. Virol. 73 1999 1427 1437
33. A. Follenzi, and L. Naldini HIV-based vectors. Preparation and use Methods Mol. Med. 69 2002 259 274
34. A.E. Sayan, A. Paradisi, B. Vojtesek, R.A. Knight, G. Melino, and E. Candi New antibodies recognizing p73: comparison with commercial antibodies Biochem. Biophys. Res. Commun. 330 2005 186 193